Related Experiment Video
Updated: Aug 29, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Molecular biology of the human immunodeficiency virus: current and future targets for intervention
1Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. pkrogstad@mednet.ucla.edu
Abstract:
Inhibitors of the reverse transcriptase and protease enzymes of the human immunodeficiency virus form the backbone of current antiretroviral therapy. However, other therapeutic targets have been identified in studies of interactions between HIV and its target cells. This review presents an overview of HIV replication, emphasizing recently recognized cellular and viral molecules that may be exploited in future pharmacological approaches to prevent and treat infection with HIV.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Human Virome
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics
Antiviral Nucleoside Inhibitors
